Tinea Corporis

9 registered clinical trials studyying Tinea Corporis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Year NCT07312604	Abeer Mohamed Abdelaziz Elkholy	N/A
Recruiting	Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis NCT07342153	Urooj Fatima	Phase 4
Completed	Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin NCT07428915	AI Labs Group S.L	—
Unknown	Efficacy and Safety of Terbinafine and Itraconazole NCT05881980	Dhaka Medical College	Phase 2 / Phase 3
Completed	Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis NCT02767947	Bausch Health Americas, Inc.	Phase 4
Completed	Pediatric Subjects With Tinea Corporis NCT02227290	Merz North America, Inc.	Phase 4
Completed	An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis NCT02466867	Merz North America, Inc.	Phase 4
Unknown	Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections NCT01105013	Laboratório Teuto Brasileiro S/A	Phase 3
Completed	Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis NCT01349998	Tinea Pharmaceuticals	Phase 3